Search Results - "Bagó, Juli"

Refine Results
  1. 1

    Engineered Mesenchymal Stem Cell/Nanomedicine Spheroid as an Active Drug Delivery Platform for Combinational Glioblastoma Therapy by Suryaprakash, Smruthi, Lao, Yeh-Hsing, Cho, Hyeon-Yeol, Li, Mingqiang, Ji, Ha Yeun, Shao, Dan, Hu, Hanze, Quek, Chai Hoon, Huang, Dantong, Mintz, Rachel L, Bagó, Juli R, Hingtgen, Shawn D, Lee, Ki-Bum, Leong, Kam W

    Published in Nano letters (13-03-2019)
    “…Mesenchymal stem cell (MSC) has been increasingly applied to cancer therapy because of its tumor-tropic capability. However, short retention at target tissue…”
    Get full text
    Journal Article
  2. 2

    Electrospun nanofibrous scaffolds increase the efficacy of stem cell-mediated therapy of surgically resected glioblastoma by Bagó, Juli R, Pegna, Guillaume J, Okolie, Onyi, Mohiti-Asli, Mahsa, Loboa, Elizabeth G, Hingtgen, Shawn D

    Published in Biomaterials (01-06-2016)
    “…Abstract Engineered stem cell (SC)-based therapy holds enormous promise for treating the incurable brain cancer glioblastoma (GBM). Retaining the cytotoxic SCs…”
    Get full text
    Journal Article
  3. 3

    Therapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma by Bagó, Juli R., Alfonso-Pecchio, Adolfo, Okolie, Onyi, Dumitru, Raluca, Rinkenbaugh, Amanda, Baldwin, Albert S., Miller, C. Ryan, Magness, Scott T., Hingtgen, Shawn D.

    Published in Nature communications (02-02-2016)
    “…Transdifferentiation (TD) is a recent advancement in somatic cell reprogramming. The direct conversion of TD eliminates the pluripotent intermediate state to…”
    Get full text
    Journal Article
  4. 4

    Tumor-homing cytotoxic human induced neural stem cells for cancer therapy by Bagó, Juli R, Okolie, Onyi, Dumitru, Raluca, Ewend, Matthew G, Parker, Joel S, Werff, Ryan Vander, Underhill, T Michael, Schmid, Ralf S, Miller, C Ryan, Hingtgen, Shawn D

    Published in Science translational medicine (01-02-2017)
    “…Engineered neural stem cells (NSCs) are a promising approach to treating glioblastoma (GBM). The ideal NSC drug carrier for clinical use should be easily…”
    Get more information
    Journal Article
  5. 5

    Fibrin matrices enhance the transplant and efficacy of cytotoxic stem cell therapy for post-surgical cancer by Bagó, Juli R, Pegna, Guillaume J, Okolie, Onyi, Hingtgen, Shawn D

    Published in Biomaterials (01-04-2016)
    “…Abstract Tumor-homing cytotoxic stem cell (SC) therapy is a promising new approach for treating the incurable brain cancer glioblastoma (GBM). However,…”
    Get full text
    Journal Article
  6. 6

    Human umbilical cord blood-derived mesenchymal stem cells promote vascular growth in vivo by Roura, Santiago, Bagó, Juli R, Soler-Botija, Carolina, Pujal, Josep M, Gálvez-Montón, Carolina, Prat-Vidal, Cristina, Llucià-Valldeperas, Aida, Blanco, Jerónimo, Bayes-Genis, Antoni

    Published in PloS one (16-11-2012)
    “…Stem cell therapies are promising strategies to regenerate human injured tissues, including ischemic myocardium. Here, we examined the acquisition of…”
    Get full text
    Journal Article
  7. 7

    Neural stem cell therapy for cancer by Bagó, Juli Rodriguez, Sheets, Kevin T., Hingtgen, Shawn D.

    Published in Methods (San Diego, Calif.) (15-04-2016)
    “…•Engineered neural stem cells (NSCs) are a promising new approach to cancer therapy.•NSCs display unique tumor-homing properties that make them ideal drug…”
    Get full text
    Journal Article
  8. 8

    A bird's-eye view of cell therapy and tissue engineering for cardiac regeneration by Soler-Botija, Carolina, Bagó, Juli R., Bayes-Genis, Antoni

    Published in Annals of the New York Academy of Sciences (01-04-2012)
    “…Complete recovery of ischemic cardiac muscle after myocardial infarction is still an unresolved concern. In recent years, intensive research efforts have…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Generation and Profiling of Tumor-Homing Induced Neural Stem Cells from the Skin of Cancer Patients by Buckley, Andrew, Hagler, Shaye B., Lettry, Vivien, Bagó, Juli R., Maingi, Spencer M., Khagi, Simon, Ewend, Matthew G., Miller, C. Ryan, Hingtgen, Shawn D.

    Published in Molecular therapy (08-07-2020)
    “…The conversion of human fibroblasts into personalized induced neural stem cells (iNSCs) that actively seek out tumors and deliver cytotoxic agents is a highly…”
    Get full text
    Journal Article
  11. 11

    Glioblastoma therapy with cytotoxic mesenchymal stromal cells optimized by bioluminescence imaging of tumor and therapeutic cell response by Alieva, Maria, Bagó, Juli R, Aguilar, Elisabet, Soler-Botija, Carolina, Vila, Olaia F, Molet, Joan, Gambhir, Sanjiv S, Rubio, Nuria, Blanco, Jerónimo

    Published in PloS one (17-04-2012)
    “…Genetically modified adipose tissue derived mesenchymal stromal cells (hAMSCs) with tumor homing capacity have been proposed for localized therapy of chemo-…”
    Get full text
    Journal Article
  12. 12

    NK92 Expressing Anti-BCMA CAR and Secreted TRAIL for the Treatment of Multiple Myeloma: Preliminary In Vitro Assessment by Motais, Benjamin, Charvátová, Sandra, Walek, Zuzana, Hájek, Roman, Bagó, Juli R

    Published in Cells (Basel, Switzerland) (30-11-2023)
    “…Multiple myeloma (MM) has witnessed improved patient outcomes through advancements in therapeutic approaches. Notably, allogeneic stem cell transplantation,…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Endothelial Differentiation of Adipose Tissue-Derived Mesenchymal Stromal Cells in Glioma Tumors: Implications for Cell-Based Therapy by Bagó, Juli R, Alieva, Maria, Soler, Carolina, Rubio, Núria, Blanco, Jerónimo

    Published in Molecular therapy (01-09-2013)
    “…Multipotent human adipose tissue mesenchymal stromal cells (hAMSCs) are promising therapy vehicles with tumor-homing capacity that can be easily modified to…”
    Get full text
    Journal Article
  15. 15
  16. 16

    A Bird's-Eye View of Cell Sources for Cell-Based Therapies in Blood Cancers by Motais, Benjamin, Charvátová, Sandra, Hrdinka, Matouš, Šimíček, Michal, Jelínek, Tomáš, Ševčíková, Tereza, Kořístek, Zdeněk, Hájek, Roman, Bagó, Juli R

    Published in Cancers (23-05-2020)
    “…Hematological malignancies comprise over a hundred different types of cancers and account for around 6.5% of all cancers. Despite the significant improvements…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds by Sheets, Kevin T, Bagó, Juli R, Paulk, Ivory L, Hingtgen, Shawn D

    Published in Journal of visualized experiments (16-07-2018)
    “…Glioblastoma (GBM), the most common and aggressive primary brain cancer, carries a life expectancy of 12-15 months. The short life expectancy is due in part to…”
    Get full text
    Journal Article
  19. 19

    Novel Local "Off-the-Shelf" Immunotherapy for the Treatment of Myeloma Bone Disease by Charvátová, Sandra, Motais, Benjamin, Czapla, Justyna, Cichoń, Tomasz, Smolarczyk, Ryszard, Walek, Zuzana, Giebel, Sebastian, Hájek, Roman, Bagó, Juli R

    Published in Cells (Basel, Switzerland) (30-01-2023)
    “…Myeloma bone disease (MBD) is one of the major complications in multiple myeloma (MM)-the second most frequent hematologic malignancy. It is characterized by…”
    Get full text
    Journal Article
  20. 20

    Bioluminescence imaging of calvarial bone repair using bone marrow and adipose tissue-derived mesenchymal stem cells by Dégano, Irene R, Vilalta, Marta, Bagó, Juli R, Matthies, Annette M, Hubbell, Jeffrey A, Dimitriou, Helen, Bianco, Paolo, Rubio, Nuria, Blanco, Jerónimo

    Published in Biomaterials (01-02-2008)
    “…Abstract A combined strategy using bioluminescence imaging, bone densitometry and histology was used to analyze the bone regeneration capacity of human bone…”
    Get full text
    Journal Article